Rak płuca: badanie fazy I leku calderasib i pembrolizumab
Phase 1 Study of MK-1084 in KRAS mutant advanced solid tumors
Badania kliniczne, które rekrutują lub wkrótce zaczną rekrutację w ośrodkach w mieście Poznań. Najwięcej badań dotyczy: rak płuca, nieswoiste zapalenia jelit, otyłość, cukrzyca.
608 badań: 565 rekrutuje, 43 wkrótce zaczną.
Phase 1 Study of MK-1084 in KRAS mutant advanced solid tumors
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
European Disease Registry on Retinopathy of Prematurity (ROP)
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC)
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated…
Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Polish Multicenter PERTs PE Outcomes Registry
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
FS222 First in Human Study in Patients With Advanced Malignancies
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Secukinumab Open Label Roll-over Extension Protocol
Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in…
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
Trifecta-Kidney cfDNA-MMDx Study
KEYMAKER-U01 Substudy 1: A Phase 2, Umbrella Study with Rolling Arms of Investigational Agents with Pembrolizumab in Combination with Chemotherapy in Treatment-Naive Patients…
Zadzwoń i porozmawiaj z doradcą ds. badań klinicznych. Sprawdzimy w rejestrach, do których badań możesz się kwalifikować.
Nie udzielamy porad ani konsultacji medycznych. Pomagamy znaleźć badanie i skontaktować się z ośrodkiem.
Informacje pochodzą z publicznych rejestrów badań klinicznych (CTIS - Unia Europejska, ClinicalTrials.gov - USA) i są aktualizowane codziennie. Mogą różnić się od aktualnego stanu w ośrodku. Ostateczną kwalifikację do badania zawsze przeprowadza lekarz w ośrodku badawczym. Stan na 3 października 2026.